Skip to main content
Premium Trial:

Request an Annual Quote

Agilent to Restructure, Cut 300 Temp Jobs and 500 Regular Positions

NEW YORK (GenomeWeb News) – Agilent Technologies disclosed in a filing with the US Securities and Exchange Commission today that it will undertake a targeted restructuring that will result in the firm cutting 300 positions from its temporary workforce and 500 positions from its regular global workforce.
 
The firm did not disclose which parts of the company would be affected by the cuts or whether they would specifically target its Bio-Analytical Measurement unit or its Electronic Measurement unit.
 
“The timing and scope of workforce reductions will vary by location based on local legal requirements,” Agilent said in the filing. “We expect to complete a majority of the activities related to the restructuring program by May 31, 2009, with the remainder expected to be completed by October 31, 2009.”
 
Agilent said that it expects the restructuring and job cuts to reduce its annual operating expenses by around $65 million.
 
In addition to the layoffs, Agilent said that it would implement, as of Jan. 1, a temporary worldwide pay reduction and/or equivalent unpaid time-off program for its employees. The firm expects that effort to yield $100 million in annual savings.
 
As a result of the restructuring, Agilent said that it expects to record a $55 million pre-tax restructuring charge, primarily related to employee severance arrangements.
 
Last week, Agilent lowered its revenue and earnings-per-share guidance for its fiscal first quarter of 2009, which ends Jan. 31, 2009.
 
The firm said that due to “deteriorating economic conditions, particularly in electronic measurement markets,” it was lowering its revenue guidance to a range of between $1.25 billion and $1.3 billion. Last month, Agilent had predicted revenue of between $1.34 billion and $1.39 billion for the first quarter.
 

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.